Introduction: Steroids and disease-modifying anti-rheumatic drugs (DMARDs) are widely used in the treatment of juvenile idiopathic arthritis (JIA). Dermatologic adverse events including psoriasis have been reported in treatment of various inflammatory diseases (1-3). However, data regarding the occurrence of dermatologic adverse events in JIA patients are scarce (4-6). Objectives: To determine the prevalence of dermatologic adverse events in JIA patients treated with systemic steroids and DMARDs. To investigate an association between drugs and dermatologic adverse events and the association between anti-TNF treatment and psoriasiform lesions.

J. Smorenburg, M.d.G. (2020). Dermatologic adverse events associated with Juvenile Idiopathic Arthritis treatment. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, 18(S2), 110-110.

Dermatologic adverse events associated with Juvenile Idiopathic Arthritis treatment

M. C. Maggio;
2020

Abstract

Introduction: Steroids and disease-modifying anti-rheumatic drugs (DMARDs) are widely used in the treatment of juvenile idiopathic arthritis (JIA). Dermatologic adverse events including psoriasis have been reported in treatment of various inflammatory diseases (1-3). However, data regarding the occurrence of dermatologic adverse events in JIA patients are scarce (4-6). Objectives: To determine the prevalence of dermatologic adverse events in JIA patients treated with systemic steroids and DMARDs. To investigate an association between drugs and dermatologic adverse events and the association between anti-TNF treatment and psoriasiform lesions.
Settore MED/38 - Pediatria Generale E Specialistica
26th European Paediatric Rheumatology Congress
23 - 26 September 2020
J. Smorenburg, M.d.G. (2020). Dermatologic adverse events associated with Juvenile Idiopathic Arthritis treatment. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, 18(S2), 110-110.
File in questo prodotto:
File Dimensione Formato  
PediatricRheumatology_2020_P110.pdf

accesso aperto

Descrizione: PRES2020_P110
Tipologia: Versione Editoriale
Dimensione 45.95 kB
Formato Adobe PDF
45.95 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/464221
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact